Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.

Nature Genetics
Steven A McCarrollDavid Altshuler

Abstract

Transplantation and pregnancy, in which two diploid genomes reside in one body, can each lead to diseases in which immune cells from one individual target antigens encoded in the other's genome. One such disease, graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT, or bone marrow transplant), is common even after transplants between HLA-identical siblings, indicating that cryptic histocompatibility loci exist outside the HLA locus. The immune system of an individual whose genome is homozygous for a gene deletion could recognize epitopes encoded by that gene as alloantigens. Analyzing common gene deletions in three HSCT cohorts (1,345 HLA-identical sibling donor-recipient pairs), we found that risk of acute GVHD was greater (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.4-4.6) when donor and recipient were mismatched for homozygous deletion of UGT2B17, a gene expressed in GVHD-affected tissues and giving rise to multiple histocompatibility antigens. Human genome structural variation merits investigation as a potential mechanism in diseases of alloimmunity.

References

Jul 7, 1984·Lancet·R P Gale, R E Champlin
Apr 15, 1994·Annals of Internal Medicine·R P GaleM M Bortin
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E H WarrenS R Riddell
May 14, 2003·The Journal of Experimental Medicine·Makoto MurataStanley R Riddell
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul J MartinRainer Storb
Jul 27, 2004·Science·Jonathan SebatMichael Wigler
Aug 3, 2004·Nature Genetics·A John IafrateCharles Lee
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman IvanovSaskia Ebeling
Oct 29, 2005·Nature·UNKNOWN International HapMap Consortium
Dec 6, 2005·Nature Genetics·Donald F ConradJonathan K Pritchard
Feb 10, 2006·Nature Genetics·Steven A McCarrollUNKNOWN International HapMap Consortium
Mar 23, 2006·Blood·Corey CutlerEdwin Alyea
Mar 24, 2007·PLoS Medicine·Effie W PetersdorfZhen Guo
Mar 13, 2008·The Journal of Clinical Endocrinology and Metabolism·Jenny Jakobsson SchulzeAnders Rane
Sep 2, 2008·American Journal of Human Genetics·Yali XueChris Tyler-Smith
Sep 9, 2008·Nature Genetics·Steven A McCarrollDavid Altshuler
Sep 24, 2008·Blood·Michi KameiYoshiki Akatsuka
Nov 11, 2008·American Journal of Human Genetics·Tie-Lin YangHong-Wen Deng

❮ Previous
Next ❯

Citations

Aug 21, 2013·International Journal of Hematology·Akiyoshi Takami
Mar 10, 2010·Expert Reviews in Molecular Medicine·Charles Lee, Stephen W Scherer
Feb 22, 2012·Bone Marrow Transplantation·C TingR Abdi
Feb 9, 2011·Immunology and Cell Biology·Marie Bleakley, Stanley R Riddell
Jun 17, 2011·Journal of Human Genetics·Chee-Seng KuAgus Salim
Mar 26, 2010·Blood·Satoko MorishimaUNKNOWN Japan Marrow Donor Program
Nov 25, 2011·The Journal of Clinical Endocrinology and Metabolism·Andrew DauberJoel N Hirschhorn
Nov 25, 2011·Pharmacogenomics·Andrea GaedigkJ Steven Leeder
Jun 3, 2010·Frontiers in Bioscience (Scholar Edition)·Udai P SinghShree Ram Singh
Feb 18, 2014·Bioinformatics·Seyed Yahya AnvarJeroen F J Laros
Aug 23, 2011·Annual Review of Genetics·Santhosh GirirajanEvan E Eichler
Jun 20, 2015·Expert Review of Molecular Diagnostics·Jayne Y Hehir-KwaJoris A Veltman
Oct 13, 2015·Bone Marrow Transplantation·M I Abu ZaidD B Miklos
Apr 10, 2012·Trends in Genetics : TIG·Rebecca C IskowCharles Lee
Sep 15, 2015·Bone Marrow Transplantation·N SantosUNKNOWN GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH)
Sep 30, 2014·Tissue Antigens·Eric Spierings
Mar 13, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·B AlmogueraB J Keating
Apr 30, 2015·Briefings in Functional Genomics·Eric R Gamazon, Barbara E Stranger
May 23, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·María José Martínez-BravoIsabel Aguilera
Jun 13, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eric SpieringsEls Goulmy
Jul 19, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Smita BhatiaJohn A Hansen
Jul 6, 2014·Urologic Oncology·Francesca Demichelis, Janet L Stanford
Jan 27, 2015·Nature Genetics·Robert E HandsakerSteven A McCarroll
Jun 13, 2014·Clinical Pharmacology and Therapeutics·C GuillemetteM Rouleau
Mar 14, 2017·Nature Reviews. Genetics·Joshua Y C Yang, Minnie M Sarwal
Feb 27, 2018·Nature Reviews. Genetics·Konrad J Karczewski, Michael P Snyder
Oct 20, 2015·Transplantation·UNKNOWN International Genetics & Translational Research in Transplantation Network (iGeneTRAiN)
Nov 26, 2009·Nature Genetics·John A L Armour
Jul 10, 2010·Current Opinion in Organ Transplantation·Charles T SpencerSebastian Joyce
Jan 19, 2013·Nature Reviews. Genetics·Joachim WeischenfeldtJan O Korbel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.